Widemile Inc., a Seattle-based provider of multivariate testing and digital content optimization for online marketers, has raised $4 million in convertible note financing. The company did not disclose participants, except to say that they included “existing investors, company management and industry insiders.” www.widemile.com
Imalux Corp., a Cleveland-based developer of technology for the visualization of tissue microstructure, has raised $5.1 million in Series C funding. Participants included Early Stage Partners, ElectroSonics Medical, Reservoir Venture Partners and Symark. www.imalux.com
Duff & Phelps Corp., a New York-based provider of financial advisory and I-banking services, raised $132.8 million in its IPO. It is the first buyout-backed IPO to price in September. Duff & Phelps priced 8.3 million common shares at $16 per share, which was below its estimated $16.50-$18.50 range. Duff & Phelps will begin trading today […]
CSAV Holding Corp. (aka Chief Manufacturing), a Savage, Minn.-based maker of audio-visual mounting equipment and display solutions, has filed for a $201.25 million IPO. It plans to trade on the NYSE, with Wachovia Securities and Piper Jaffray serving as co-lead underwriters. Friedman Fleischer & Lowe led a 2003 buyout of CSAV, and currently stands as majority […]
Ulta Salon, Cosmetics & Fragrance, a Romeoville, Ill.-based beauty retailer and salon operator, has set its IPO terms to around 8.55 million common shares being offered at between $14 and $16 per share. It would have an initial market cap of approximately $907 million, were it to price at the high end of its range. […]
Trans1 Inc., a Wilmington, N.C.-based developer of a surgical device for treating a degenerative disc disease affecting the lower lumbar region of the spine, has set its IPO terms to 5.5 million common shares being offered at between $12 and $14 per share. The company's initial market cap would be approximately $262.87 million, if it […]
Ceres Inc., a Thousand Oaks, Calif.-based developer of energy crops that can be planted as feedstocks for cellulosic ethanol production, has raised $75 million in Series F funding led by Warburg Pincus. The Galleon Group also participated, alongside return backers Artal Luxembourg, Oxford Bioscience Partners, GIMV, H&Q, KBC, Monsanto Co., Oppenheimer Funds, QuestMark Partners […]
Sinexus Inc. has raised $3.5 million in Series A funding from Kleiner Perkins Caufield & Buyers and U.S. Venture Partners, according to a regulatory filing. The Palo Alto, Calif.-based medical device company is focused on the treatment of chronic sinusitis, an inflammatory disease affecting the paranasal sinuses.
OpTrip Inc., a Sunnyvale, Calif.-based developer of automated online travel planning technology, has raised $500,000 in Series A funding. Backers include angel group Amidzad Partners and Peter Thiel. www.optrip.com
Sequel Pharmaceuticals, a San Diego-based developer of a drug candidate for the treatment of atrial fibrillation, has raised $20 million in Series A funding. Sequel recently spun out of NovaCardia, following that company's acquisition by Merck & Co.The $20 million came from past NovaCardia backers Domain Associates, Forward Ventures, InterWest Partners, Montreux Equity Partners and Skyline Venture.